Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
Apr 21, 2026 - 01:10:08
Radio and PodcastLive Radio & PodcastsEmily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman. Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molec...
This episode belongs to The Long Run with Luke Timmerman.
Use the player on this page to stream the episode online.
Published Dec 15, 2025, 01:07:34 long, audio available.
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
You can listen to Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease online on Radio and Podcast. Open the player on this page to stream the available audio.
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
This episode is 01:07:34 long.
This episode was published on Dec 15, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Long Run with Luke Timmerman when more episodes are available from the podcast feed.
You can listen to Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease on this page when the episode audio is available from the podcast feed.
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease is from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
Published Dec 15, 2025 and 01:07:34 long